Angioarchitectural Characteristics Associated with Complications of Embolization in Supratentorial Brain Arteriovenous Malformation

References

1. 1.↵
   1. Chang SD,
   2. Marcellus ML,
   3. Marks MP,
   4. et al

   . Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery 2003;53:1–11

   PubMedWeb of Science
2. 2.↵
   1. Taylor CL,
   2. Dutton K,
   3. Rappard G,
   4. et al

   . Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg 2004;100:810–12

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Izawa M,
   2. Chernov M,
   3. Hayashi M,
   4. et al

   . Combined management of intracranial arteriovenous malformations with embolization and gamma knife radiosurgery: comparative evaluation of the long-term results. Surg Neurol 2009;71:43–53

   CrossRefPubMed
4. 4.↵
   1. Van Rooij WJ,
   2. Sluzewski M,
   3. Beute GN

   . Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 2007;28:172–77

   Abstract/FREE Full Text
5. 5.↵
   1. Katsaridis V,
   2. Papagiannaki C,
   3. Aimar E

   . Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008;50:589–97

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Pan JW,
   2. Zhou HJ,
   3. Zhan RY,
   4. et al

   . Supratentorial brain AVM embolization with Onyx-18 and post-embolization management: a single-center experience. Intervent Neuroradiol 2009;15:275–82
7. 7.↵
   1. Ledezma CJ,
   2. Hoh BL,
   3. Carter BS,
   4. et al

   . Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery 2006;58:602–11

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Haw CS,
   2. terBrugge K,
   3. Willinsky R,
   4. et al

   . Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 2006;104:226–32

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Cockroft KM,
   2. Hwang SK,
   3. Rosenwasser RH

   . Endovascular treatment of cerebral arteriovenous malformations: indications, techniques, outcome, and complications. Neurosurg Clin North Am 2005;16:367–80

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Kim LJ,
    2. Albuquerque FC,
    3. Spetzler RF,
    4. et al

    . Postembolization neurological deficits in cerebral arteriovenous malformations: stratification by arteriovenous malformation grade. Neurosurgery 2006;58:53–59
11. 11.↵
    1. Panagiotopoulos V,
    2. Gizewski E,
    3. Asgari S,
    4. et al

    . Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 2009;30:99–106

    Abstract/FREE Full Text
12. 12.↵
    1. Ogilvy CS,
    2. Stieg PE,
    3. Awad I,
    4. et al

    . AHA Scientific Statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council. Stroke 2001;32:1458–71

    FREE Full Text
13. 13.↵
    1. Viñuela F,
    2. Duckwiler G,
    3. Guglielmi G

    . Contribution of interventional neuroradiology in the therapeutic management of brain arteriovenous malformations. J Stroke Cerebrovasc Dis 1997;6:268–71

    CrossRefPubMed
14. 14.↵
    1. Hartmann A,
    2. Mast H,
    3. Mohr JP,
    4. et al

    . Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke 2005;36:2431–35

    Abstract/FREE Full Text
15. 15.↵
    1. Morgan MK,
    2. Zurin AA,
    3. Harrington T,
    4. et al

    . Changing role for preoperative embolisation in the management of arteriovenous malformations of the brain. J Clin Neurosci 2000;7:527–30

    CrossRefPubMed
16. 16.↵
    1. Martin NA,
    2. Khanna R,
    3. Doberstein C,
    4. et al

    . Therapeutic embolization of arteriovenous malformations: the case for and against. Clin Neurosurg 2000;46:295–318

    PubMed
17. 17.↵
    1. Viñuela F,
    2. Dion JE,
    3. Duckwiler G,
    4. et al

    . Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg 1991;75:856–64

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Weber W,
    2. Kis B,
    3. Siekmann R,
    4. et al

    . Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery 2007;61:244–52

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Jayaraman MV,
    2. Marcellus ML,
    3. Hamilton S,
    4. et al

    . Neurologic complications of arteriovenous malformation embolization using liquid embolic agents. AJNR Am J Neuroradiol 2008;29:242–46

    Abstract/FREE Full Text
20. 20.↵
    1. Starke RM,
    2. Komotar RJ,
    3. Otten ML,
    4. et al

    . Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits. Stroke 2009;40:2783–90

    Abstract/FREE Full Text
21. 21.↵
    1. Hauck EF,
    2. Welch BG,
    3. White JA,
    4. et al

    . Preoperative embolization of cerebral arteriovenous malformations with Onyx. AJNR Am J Neuroradiol 2009;30:492–95

    Abstract/FREE Full Text
22. 22.↵
    1. Velat GJ,
    2. Reavey-Cantwell JF,
    3. Sistrom C,
    4. et al

    . Comparison of N-butyl cyanoacrylate and Onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times. Neurosurgery 2008;63:ONS73–78

    PubMed
23. 23.↵
    NBCA Trial Investigators. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 2002;23:748–55

    Abstract/FREE Full Text
24. 24.↵
    1. Schmutz F,
    2. McAuliffe W,
    3. Anderson DM,
    4. et al

    . Embolization of cerebral arteriovenous malformations with silk: histopathologic changes and hemorrhagic complications. AJNR Am J Neuroradiol 1997;18:1233–37

    Abstract
25. 25.↵
    1. Mathis JA,
    2. Barr JD,
    3. Horton JA,
    4. et al

    . The efficacy of particulate embolization combined with stereotactic radiosurgery for treatment of large arteriovenous malformations of the brain. AJNR Am J Neuroradiol 1995;16:299–306

    Abstract/FREE Full Text
26. 26.↵
    1. Deruty R,
    2. Pelissou-Guyotat I,
    3. Amat D,
    4. et al

    . Complications after multidisciplinary treatment of cerebral arteriovenous malformations. Acta Neurochir (Wien) 1996;138:119–31

    CrossRefPubMed
27. 27.↵
    1. Frizzel RT,
    2. Fisher WS 3rd.

    . Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery 1995;37:1031–39

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Picard L,
    2. DaCosta E,
    3. Anxionnat R,
    4. et al

    . Acute spontaneous hemorrhage after embolization of brain arteriovenous malformation with N-butyl cyanoacrylate. J Neuroradiol 2001;28:147–65

    PubMedWeb of Science
29. 29.↵
    1. Jafar JJ,
    2. Davis AJ,
    3. Berenstein A,
    4. et al

    . The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 1993;78:60–69

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Purdy PD,
    2. Batjer HH,
    3. Samson DS

    . Management of hemorrhagic complications from preoperative embolization of arteriovenous malformations. J Neurosurg 1991;74:205–11

    CrossRefPubMed
31. 31.↵
    1. Massoud TF,
    2. Hademenos GJ,
    3. Young WL,
    4. et al

    . Can induction of systemic hypotension help prevent nidus rupture complicating arteriovenous malformation embolization? Analysis of underlying mechanism achieved using a theoretical model. AJNR Am J Neuroradiol 2000;21:1255–67

    Abstract/FREE Full Text
32. 32.↵
    1. Hademenos GJ,
    2. Massoud TF

    . Risk of intracranial arteriovenous malformation rupture due to venous drainage impairment: a theoretical analysis. Stroke 1996;27:1072–83

    Abstract/FREE Full Text
33. 33.↵
    1. Spetzler RF,
    2. Wilson CB,
    3. Weinstein P,
    4. et al

    . Normal perfusion pressure breakthrough theory. Clin Neurosurg 1978;25:651–72

    PubMed
34. 34.↵
    1. Heidenreich JO,
    2. Hartlieb S,
    3. Stendel R,
    4. et al

    . Bleeding complications after endovascular therapy of cerebral arteriovenous malformations. AJNR Am J Neuroradiol 2006;27:313–16

    Abstract/FREE Full Text
35. 35.↵
    1. Debrun GM,
    2. Aletich V,
    3. Ausman JI,
    4. et al

    . Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997;40:112–20

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Hartmann A,
    2. Pile-Spellman J,
    3. Stapf C,
    4. et al

    . Risk of endovascular treatment of brain arteriovenous malformations. Stroke 2002;33:1816–20

    Abstract/FREE Full Text
37. 37.↵
    1. Lawton MT

    . Spetzler-Martin grade III arteriovenous malformations: surgical results and a modification of the grading scale. Neurosurgery 2003;52:740–48

    CrossRefPubMed
38. 38.↵
    1. Gobin YP,
    2. Laurent A,
    3. Merienne L,
    4. et al

    . Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 1996;85:19–28

    CrossRefPubMedWeb of Science